Physician profile
Kurt Johnson
NPI 1306292206
$28,383.83
in general payments reported to CMS, 2019-2025
23 companies · $3,172 in 2025
The $3,172 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,837 · 2020: $364 · 2021: $8,010 · 2022: $5,757 · 2023: $3,421 · 2024: $4,823 · 2025: $3,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,025 · Food and Beverage: $4,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,024.94 |
| Food and Beverage | $4,390.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13,219.85 | 2021-2025 | Or3o Dual Mobility, Ri Hip Navigation, Journey |
| Stryker Corporation | $7,068.42 | 2019-2025 | Mako, Gamma, T2 |
| Zimmer Biomet Holdings, INC. | $4,264.89 | 2019-2024 | Persona |
| Exactech, INC. | $951.90 | 2019 | |
| Medinc of Texas | $745.00 | 2019 | |
| Depuy Synthes Sales INC. | $537.49 | 2019-2025 | Monovisc, Orthovisc |
| Globus Medical, INC. | $293.79 | 2021-2023 | A/R Femoral Nail |
| Bioventus LLC | $245.76 | 2020-2024 | Durolane, Durolane |
| Pacira Therapeutics, INC. | $227.69 | 2021 | |
| Total Joint Orthopedics, INC. | $225.70 | 2023 | |
| Bone Support INC. | $143.73 | 2025 | Cerament G, Ceramentbone Void Filler |
| Orthalign INC | $114.51 | 2021 | |
| Medical Device Business Services, INC. | $62.98 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $42.66 | 2019-2021 | |
| Becton, Dickinson and Company | $37.48 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $34.33 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pylant Medical | $32.48 | 2023 | |
| Flower Orthopedics Coporation | $27.29 | 2024 | |
| Innovation Technologies INC | $24.83 | 2025 | Irrisept |
| Kerecis Limited | $24.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Cardiovascular Systems INC. | $24.37 | 2023 | Diamondback Peripheral |
| Solventum Corporation | $19.12 | 2025 | V.A.C.Ulta, Prevena |
| Baxter Healthcare | $14.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.